Date published: 2026-2-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

PHYHIPL Activators

PHYHIPL activators encompass a diverse range of chemical compounds that exert their effects through various biochemical mechanisms to enhance the protein's functional activity. For instance, certain small molecules directly stimulate enzymes such as adenylyl cyclase, leading to an increase in intracellular cAMP levels, which are known to influence diverse cellular pathways, and could thereby enhance the activity of PHYHIPL. Other activators include inhibitors of phosphodiesterases, which prevent the degradation of cAMP and cGMP, again contributing to conditions that may favor the activation of PHYHIPL. Additionally, the use of compounds that mimic the cellular energy state, like AMP analogs, activates AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis, which in turn can initiate a cascade of signaling events that promote PHYHIPL activation. Moreover, the modulation of cell cycle progression through the inhibition of cyclin-dependent kinases may create a cellular environment conducive to the upregulation of PHYHIPL.

The regulation of PHYHIPL activity can also be influenced by compounds that affect gene expression through epigenetic mechanisms. Histone deacetylase (HDAC) inhibitors, for example, lead to increased acetylation of histones and may cause upregulation of PHYHIPL, altering its expression levels and potentially its activity. Cellular stress responses such as autophagy, induced by certain polyamines, provide another route through which the activity of PHYHIPL could be indirectly increased. This is due to the autophagic process potentially clearing cellular debris and misfolded proteins, thus potentially affecting the function of PHYHIPL. Additionally, the administration of NAD+ precursors and related sirtuin activators may also influence the activity of PHYHIPL through post-translational modifications such as deacetylation. Furthermore, modulation of signaling pathways by inhibitors of glycogen synthase kinase-3β (GSK-3β) or phosphoinositide 3-kinases (PI3K) can create a milieu that indirectly supports the activation of PHYHIPL, thereby influencing its role within the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Directly stimulates adenylyl cyclase, increasing cAMP levels which can enhance the activity of PHYHIPL.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor, elevates cAMP and cGMP which may indirectly activate PHYHIPL.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AMP analog that activates AMPK, which can lead to downstream events promoting PHYHIPL activation.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Inhibits cyclin-dependent kinases, altering cell cycle progression and possibly upregulating PHYHIPL.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, which can modulate pathways linked to PHYHIPL activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor leading to hyperacetylation of histones, possibly causing increased expression of PHYHIPL.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

HDAC inhibitor that can result in enhanced acetylation and potential upregulation of PHYHIPL.

Spermidine

124-20-9sc-215900
sc-215900B
sc-215900A
1 g
25 g
5 g
$57.00
$607.00
$176.00
(2)

Induces autophagy which could lead to cellular conditions favoring PHYHIPL activity.

β-Nicotinamide mononucleotide

1094-61-7sc-212376
sc-212376A
sc-212376B
sc-212376C
sc-212376D
25 mg
100 mg
1 g
2 g
5 g
$110.00
$150.00
$220.00
$300.00
$600.00
4
(1)

NAD+ precursor, enhancing sirtuin activity which may indirectly activate PHYHIPL through deacetylation.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Sirtuin activator, can enhance deacetylation processes potentially linked to PHYHIPL regulation.